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Viral kinetics have been extensively studied in the past through the use of spatially homogeneous
ordinary differential equations describing the time evolution of the diseased state. However, spatial
characteristics such as localized populations of dead cells might adversely affect the spread of infec-
tion, similar to the manner in which a counter-fire can stop a forest fire from spreading. In order to
investigate the influence of spatial heterogeneities on viral spread, a simple 2-D cellular automaton
(CA) model of a viral infection has been developed. In this initial phase of the investigation, the
CA model is validated against clinical immunological data for uncomplicated influenza A infections.
Our results will be shown and discussed.
I. INTRODUCTION
In the past two decades, many approaches have been chosen to model different aspects of the immune system.
Differential equation models are perhaps the most common and are typically used to simulate the immunological and
epidemiological dynamics of particular diseases to try and identify the critical parameters involved [3, 16]. Genetic
algorithms have been applied to the modelling of the evolution of diversity and pattern recognition capability in the
immune system [8, 10, 11]. On the theoretical front, some ingenious work [6, 15, 20, 22] has been done to understand
aspects of the immune system from the perspective of optimization problems. Efforts to build an immune system
tailored for computer networks [7, 21] have raised our understanding of the crucial nature of certain immune system
mechanisms. Cellular automaton (CA) models have been developed to simulate the immune dynamics of particular
diseases [27], to model shape space interactions [26] based on the network theory introduced by Jerne [12], and have
been chosen as the tool of choice to implement highly complex general immune system simulators [2, 4, 14, 19] that
are to be used to run immune system experiments in machina. More recently, a promising stage-structured modelling
approach was used to study cytotoxic T lymphocyte response to antigen [5].
Of all of the above, ordinary differential equations are the most commonly used method to model disease dynamics.
By using ordinary differential equations — which describe a system assuming it is homogeneous in space — to study
viral kinetic, one chooses not to take into consideration spatial characteristics that could potentially play a nontrivial
role in the development and outcome of a viral infection. Here, the authors introduce a cellular automaton model
that will be used in later work to study the influence of spatial heterogeneities on the dynamical evolution of a viral
infection. In this first step of the project, the CA model is used to simulate an uncomplicated infection with the
influenza A virus in order to verify that it is not only capable of replicating the typical shape of an immune response
to an uncomplicated viral infection, but that it can also give quantitatively reasonable results when parameterized
for a particular viral infection. In Section II, we give a brief description of the nature of influenza. In Section III, we
describe the structure and evolution rules of the CA model. In Section IV, we present results from the CA simulations
and compare them against data from the literature. Finally, in Section V, we expand on the biological meaning of the
model’s parameters, how we have arrived at the values we chose for the model, and examine the model’s sensitivity
to their values.
II. ABOUT INFLUENZA A
Influenza, in humans, is caused by a virus that attacks mainly the upper respiratory tract, the nose, throat and
bronchi and rarely also the lungs. According to the World Health Organization (WHO), the annual influenza epidemics
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2affect from 5% to 15% of the population and are thought to result in between three and five million cases of severe
illness and between 250 000 and 500 000 deaths every year around the world. Most deaths currently associated with
influenza in industrialized countries occur among the elderly over 65 years of age [25].
Influenza viruses are divided into three groups: A, B, and C. Additionally, influenza viruses are defined by two
different protein components, known as antigens, on the surface of the virus. They are spike-like features called
haemagglutinin (H) and neuraminidase (N) components. Influenza A has two subtypes which are important for
humans: A(H3N2) and A(H1N1), of which the former is currently associated with most deaths. Antibodies to H
are strain-specific and neutralize the infectivity of the influenza A virus, while antibodies to N have a less protective
effect. Thus, it is suggested in [3] that the the antigenic properties of influenza A virus be associated with the H
determinant.
It is the high mutation capability of the influenza virus that makes it a great public health concern. The genetic
makeup of influenza viruses allows for frequent minor genetic mutations to take place. This makes it necessary to
constantly monitor the global influenza situation in order to adjust the influenza vaccines’ virus composition annually
to include the most recent circulating influenza A(H3N2), A(H1N1) and influenza B viruses. Additionally, influenza
A viruses, including subtypes from different species, can swap, reassort, and merge genetic material resulting in novel
subtypes. Three times in the last century, influenza A viruses have undergone major genetic changes mainly in their
H-component, resulting in global pandemics and large tolls in terms of both disease and deaths [24].
III. THE CELLULAR AUTOMATON MODEL
Our CA model considers two species: epithelial cells, which are the target of the viral infection, and immune cells
which fight the infection. The virus particles themselves are not explicitly considered, rather the infection is modelled
as spreading directly from one epithelial cell to another. The CA is run on a two-dimensional square lattice where
each site represents one epithelial cell. Immune cells are mobile, moving from one lattice site to another, and their
population size is not constant. The CA lattice is therefore like a tissue of immobile cells which is patrolled by the
mobile immune cells. The CA is updated synchronously (i.e. all cells are time-stepped at once rather than one cell at
a time). The boundary conditions for both the epithelial and immune cells are toroidal, i.e. an immune cell moving off
one edge of the grid are reintroduced at the opposite edge and an infectious epithelial cell at one edge of the grid can
infect healthy cells located at the opposite edge. Finally, the neighbourhood of a lattice site is defined as consisting of
the 8 closest sites. Infected epithelial cells can only infect their 8 surrounding neighbours and immune cells can move
at a speed of 1 site per time step to any of the 8 neighbour sites or remain in place. Below are the detailed evolution
rules for each of the cell species.
Epithelial Cells An epithelial cell can be in any of five states: healthy, infected, expressing, infectious, or dead.
Transitions between epithelial cell states occur as follows:
• Epithelial cells of all states become dead when they are older than CELL LIFESPAN.
• A healthy epithelial cell becomes infected with probability INFECT RATE/(8 nearest neighbours) for each
infectious nearest neighbour.
• An infected cell becomes expressing, i.e. begins expressing the viral peptide, after having been infected for
EXPRESS DELAY.
• An expressing cell becomes infectious after having been infected for INFECT DELAY > EXPRESS DELAY.
• Infected, expressing, and infectious cells become dead after having been infected for INFECT LIFESPAN.
• Expressing and infectious cells become dead when “recognized” by an immune cell. See below for the
meaning of “recognition.”
• A dead cell is revived at a rate DIVISION TIME−1×# healthy/# dead. When revived, a dead cell becomes
a healthy cell or an infected cell with probability INFECT RATE/(8 nearest neighbours) for each infectious
nearest neighbour.
A simulation is initialized with each epithelial cell being assigned a random age between 0 and CELL LIFESPAN
inclusively. All epithelial cells start in the healthy state with the exception of a fraction INFECT INIT of the
total number of epithelial cells which, chosen at random, are set to the infected state.
Immune Cells An immune cell can be in any of two states: virgin or mature. A virgin cell is an immune cell that
has no specificity. A mature cell is an immune cell that has either already encountered an infected cell or has
been recruited by another mature immune cell.
3• Immune cells move randomly on the CA lattice at a speed of one lattice site per time step.
• An immune cell is removed if it is older than IMM LIFESPAN.
• An encounter between an immune cell and an expressing or infectious epithelial cell requires the immune
cell to be in the same site as the expressing or infectious cell.
• A virgin immune cell becomes a mature immune cell if the lattice site it is occupying is in the expressing
or infectious states.
• A mature immune cell occupying an expressing or infectious lattice site “recognizes” the epithelial cell and
causes it to become dead.
• Each recognition event causes RECRUITMENT mature immune cells to be added at random sites on the CA
lattice after a delay of RECRUIT DELAY.
• Virgin immune cells are added at random lattice sites as needed to maintain a minimum density of
BASE IMM CELL virgin immune cells.
A simulation is initialized with a density of BASE IMM CELL virgin immune cells at random locations on the CA
lattice, each with a random age.
Implicit in this model are the following physiological assumptions:
• Only healthy epithelial cells are able to divide.
• Immune cells cannot be infected and so only ever die of old age.
• No memory immune cells are considered. Memory could be added by setting an extended lifespan to a given
proportion of immune cells created during a viral invasion.
• We consider a single viral strain with no mutation. This implies the existence of a single, unique, epitope
identifying the infection.
IV. RESULTS
A great deal is known about the influenza virus including viral structure and composition, the replication process,
and even some dynamical data regarding the viral and antibody titer over the course of the infection [1, 9, 13].
However, key dynamical information such as the flow rate of immune cells within an infected tertiary lymphoid organ,
the clearance rate of viral particles, the lifespan of an infected epithelial cell, is either uncorroborated, unknown, or
known with poor precision. In our model, all but two parameters have been taken directly or adapted from [3]. They
are presented in Table I along with their value and description.
Due to the limited dynamical information available for influenza A, there are only a few quantitative characteristics
against which we can compare our model. They are:
1. The infection should peak on day 2 (48 h) [3, 9].
2. Over the course of the infection, the fraction of epithelial cells that are dead should be as follows [3]:
(a) 10% on day 1 (24 h);
(b) 40% on day 2 (48 h);
(c) 10% on day 5 (120 h).
3. From [3], virus concentration should decline to inoculation level on day 6 (144 h). From [9], experimental data
recovered from 8 volunteers indicated that virus shedding persisted for 5± 2 d (72–168 h).
4. The number of immune cells should peak anywhere between day 2 (macrophages’ peak) and day 7 (cytotoxic T
cells’ and B cells’ peak) (48 h–168 h) [3].
5. At their peak, the number of B cells, helper T cells, and cytotoxic T cells should be 100-fold greater than their
normal concentration, while that of plasma cells should be 104-fold greater [3].
4Parameter Value Description
grid width 440 Width of the grid (cells)
grid height 280 Height of the grid (cells)
FLOW RATE 6 ts/h Speed of immune cells (time steps/hour)
IMM LIFESPAN 168 h Lifespan of an immune cell
CELL LIFESPAN 380 h Lifespan of a healthy epithelial cell
INFECT LIFESPAN 24 h Lifespan of an infected epithelial cell
INFECT INIT 0.01 Fraction of initially infected cells
INFECT RATE 2 h−1 Rate of infection of neighbours
INFECT DELAY 6 h Delay from infected to infectious
EXPRESS DELAY 4 h Delay from infected to viral expression
DIVISION TIME 12 h Duration of an epithelial cell division
BASE IMM CELL 1.5× 10−4 Minimum density of immune cells per epithelial cell
RECRUIT DELAY 7 h Delay between the recruitment call and the addition of immune cells
RECRUITMENT 0.25 Number of immune cells recruited when one recognizes the virus
TABLE I: The model’s default parameters extracted from [3].
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FIG. 1: Simulation results averaged over 10 simulation runs using the parameter set presented in Table I. The paired lines
mark one standard deviation and represent the proportion of epithelial cells that are healthy (dashes), containing the influenza
A virus particles (dots), dead (solid), as well as the proportion of immune cells per epithelial cell (dots and dashes).
The simulation results for the default parameters presented in Table I are shown in Figure 1. The infection peaks
on day 2, and although there are fewer than 10% of the cells dead on days 1 and 5, there is 40% of the cells dead
on day 2. Recovery from the infection is faster than experimental data suggests, but this is probably mainly due to
the fact that immune cells in our model are generic. During a true influenza A infection, the first part of the immune
response is dominated by macrophages and T cells while the later part is dominated by the action of antibodies, a
subtelty that is missed by our bulk model. The number of immune cell does peak between day 2 and 7, with an
approximate 1000-fold increase from the normal concentration set by BASE IMM CELL.
V. DISCUSSION OF THE PARAMETERS OF THE MODEL
Some of the model’s parameters have quite a large uncertainty. In some cases this is a reflection of the difficulty of
measuring the parameter while in other cases it is a reflection of the variation between individuals. The model also
has two free parameters, RECRUITMENT and INFECT RATE, whose values are not known from physiological data. Here,
we will discuss each parameter in detail and investigate the sensitivity of the model their variation.
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FIG. 2: Effects of the lattice size on the dynamics of the infection. The greyed areas represent one standard deviation after
10 runs while increasing darkness represents increasing grid sizes of 7,700 cells, 30,800 cells, 123,200 cells, 1,971,200 cells, and
9,432,500 cells. For clarity, the inset shows a detail of the healthy cell curves alone. Increasing the grid size is seen to not affect
the average behaviour but decreases the standard deviation.
A. grid width and grid height
Since each lattice site represents an epithelial cell and the width and height of the grid are given in numbers
of epithelial cells, it is possible to calculate the physical size of the simulation. The model’s default lattice has
grid width × grid height = 123, 200 cell sites. In uninflamed tissue, there are about 2,200 ciliated cells per
square millimetre of epithelial area [3]. Taking ciliated cells — which account for 60% ∼ 80% of internal bronchial
surfaces — to correspond to each lattice site of the CA model, the real-life size of the default lattice is about
123200 cells/2200 cells ·mm−2 = 56 mm2. When inflamed, there are about 700 cells per square millimetre of epithe-
lial tissue area, giving the simulation a real-life area of 176 mm2.
To test the sensitivity of the model’s algorithm to changes in lattice size, i.e. to determine if the finite nature of
the simulation influences the results, simulations have been run with lattices ranging from 7,700 cells to 9,432,500
cells (the most that could be simulated with the 512 MiB of RAM available in the simulation machine). The results
obtained for several lattice sizes in this range are presented in Figure 2. What one sees from this plot is that the
average behaviour of the model is unchanged by modifications to the size of the simulation area, but that the standard
deviation of the behaviour about the mean decreases as the simulation area is increased. This is consistent with the
interpretation of the results from a single simulation run on a large grid as being equivalent to averaged results from
several simulations run on smaller grids. This would be the case — that a large simulation is equivalent to an average
over several smaller simulations — anytime the simulation size itself does not play a role in the dynamics, and so
observing this behaviour strongly suggests that the default lattice size is sufficiently large for its finite nature to be
unimportant.
B. FLOW RATE
Due to the discrete nature of a cellular automaton, immune cells move by increments of one lattice site per time
step. Because each lattice site represents one epithelial cell, each time step has to represent the true time required
for an immune cell to go from one epithelial cell to the next. Very little is known about the speed at which immune
cells patrol tertiary lymphoid organs or by how much the flow will vary depending on whether the area is healthy or
infected. This has made the model’s time scale difficult to establish.
All time dependent parameters in the model are scaled by a parameter named FLOW RATE which is defined as the
number of CA time steps corresponding to 1 h in real time. The duration of the CTL lethal hit process, i.e. the time
it takes for a cytotoxic T lymphocyte to kill an infected cell, is about tattack = 20 min ∼ 30 min [3]. One can suppose
that an immune cell that is not involved with, or in the process of destroying, an infected cell will move from one
epithelial cell to the next in less time, say tfree. Since on average about 15% of cells are infected over the course of
the infection for the default set of parameters chosen for the model (see Figure 1), one can compute the average time
it takes for an immune cell to go from one epithelial cell to the next as tavg = 0.15× tattack + 0.85× tfree. Assuming
that tfree can be anywhere between negligible, ≈ 0 min, to at most 30 min, then tavg can range from 3 min to 30 min,
which corresponds to a range of 2 to 20 time steps per hour for FLOW RATE. We have chosen to set FLOW RATE to
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FIG. 3: The effect of varying FLOW RATE on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using FLOW RATE values of 2, 6, and 20 time steps/h respectively (the physiologically plausible range). The central
graph is the same as Figure 1. These show that the simulation is sensitive to the parameter FLOW RATE.
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FIG. 4: The effect of varying IMM LIFESPAN on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using IMM LIFESPAN values of 48 h, 168 h, and 480 h respectively. The central graph is the same as Figure 1. These
show that the simulation is only sensitive to the parameter IMM LIFESPAN when its value is smaller than the time required for
the immune cells to clear the infection.
6 time steps/h, which means that immune cells move at a speed of one epithelial cell per 10 min. Note that this
corresponds to a tfree of about 6 min ∼ 8 min, but we have found no experimental value in the literature to compare
this to.
Figure 3 shows the effect of varying FLOW RATE throughout this range. The faster the immune cells move (the larger
FLOW RATE is), the bigger the advantage they will have over the growth of the infection and thus the less pronounced
the infection. This is clearly illustrated in Figure 3 where the smallest value of FLOW RATE results in a lethal infection
while the largest value results in a minor infection. The CA model is extremely sensitive to this particular parameter
and therefore it would be important for future work to determine this parameter with greater precision.
C. IMM LIFESPAN
The problem in defining this particular parameter with much precision comes from the fact that the immune cells
in our CA model are generic, i.e. they do not represent a particular species of immune cell such as cytotoxic T cells
or plasma B cells, rather they represent the combined action of all involved species of immune cells. In [3], the rate
constants of natural death for immune cells range from 0.05 d−1 for B cells to 0.5 d−1 for cytotoxic T cells and plasma
B cells. This corresponds to an immune lifespan range of 48 h ∼ 480 h. For our model, we chose an immune cell
lifespan of 168 h as the default value. In Figure 4, the dynamics resulting from the use of a 48 h and 480 h immune
cell lifespan is shown. In broadest terms there are two outcomes and which one is observed depends on whether the
immune cell lifespan is greater than or less than the time required for the immune cells to completely eliminate the
infection. When the immune cell lifespan is less than the time required to clear the infection, all cell populations
oscillate, much in the manner of a predator-prey system — a situation which may be referred to as a chronic infection.
When the immune cell lifespan is greater than the time required to clear the infection, it does just that.
From Figure 4, it can be seen that only at the very bottom end of the physiologically plausible range for the
parameter IMM LIFESPAN does its value begin to influence the model’s dynamics. Over most of this parameter’s
range, the infection is killed too early for the immune cell lifespan to be important. Since experimental data indicates
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FIG. 5: The effect of varying DIVISION TIME on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using DIVISION TIME values of 7 h, 12 h, and 24 h respectively. The central graph is the same as Figure 1. These
show that the simulation is sensitive to the parameter DIVISION TIME.
that the virion concentration should have declined to inoculation level no later than 144 h (6 d) into the infection, we
chose a value for the immune lifespan that is slightly larger than this, namely 168 h (7 d).
D. DIVISION TIME
The duration of a single division of an epithelial cell is about 0.3 d ∼ 1 d [3]. We chose a value of 12 h (0.5 d) for the
model parameter DIVISION TIME. Assuming that only healthy cells can undergo successful division, the probability
per unit time that any dead cell is revived is given by
P (dead→ alive) =
1
DIVISION TIME
×
# healthy cells
# dead cells
.
Figure 5 shows the effect of varying DIVISION TIME over its physiologically allowed range of 7 h to 24 h. One
sees that this parameter can have a significant effect on the dynamics and even on the outcome of the infection.
DIVISION TIME represents the capacity of the system to regenerate itself: the greater the regenerative power of the
system — the smaller DIVISION TIME — the better its chances of recuperating after a severe infection. In this model,
at the high end of DIVISION TIME’s range there is a tendency for the influenza A infection to kill the host, while at
the low end of its range the epithelial cell regeneration rate is too high to reproduce the level of damage observed
experimentally. We chose a default value of 12 h for our model. With this value, 40% of the epithelial cells are dead
at the peak of the infection which is in agreement with the experimental data.
E. CELL LIFESPAN
An epithelial cell, in vitro, can go through 20 to 25 population doublings in its lifespan [18]. Each population
doubling lasts for DIVISION TIME, so the lifespan of an epithelial cell should be about 160 h ∼ 600 h. We chose
the mid-range value of 380 h as the default for our model. One impediment to finding more precise information
about epithelial cell lifespans is that most in vitro research is done using cell lines that have been made immortal.
Additionally, there is much variability in cell lifespan across cell types. In any case, even the lower bound of 160 h
is longer than the duration of an uncomplicated influenza A infection and thus the value of CELL LIFESPAN, within
the physiologically plausible range, should have little effect on the results. Figure 6 shows the dynamics of the viral
infection for cell lifespans at the physiologically allowed extrema of 160 h and 600 h as well as at the default mid-
range value of 380 h. In the model, one consequence of the en masse killing of epithelial cells by the viral infection
is the synchronization of the ages of newly-grown epithelial cells. This is seen as a cell-death “echo” approximately
CELL LIFESPAN h after the peak of the infection. The only visible difference between simulations run with different
values of CELL LIFESPAN is a change in the time at which the cell-death echo occurs.
F. EXPRESS DELAY, INFECT DELAY, and INFECT LIFESPAN
When an epithelial cell becomes infected by an influenza A virion, 4 h (EXPRESS DELAY) elapse before it can start
expressing viral antigen and thus be recognized by an immune cell [3]. It will take the infected cell an additional 2 h
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FIG. 6: The effect of varying CELL LIFESPAN on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using CELL LIFESPAN values of 160 h, 380 h, and 600 h respectively. The central graph is the same as Figure 1. These
show that the simulation is not sensitive to the parameter CELL LIFESPAN.
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FIG. 7: The effect of varying INFECT INIT on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using INFECT INIT values of 0.001, 0.01, and 0.1 respectively. The central graph is the same as Figure 1. These show
that the simulation is sensitive to the parameter INFECT INIT.
(INFECT DELAY = 6 h) to begin releasing virus particles and thus become infectious [3]. Ultimately, influenza A virus
being highly cytopathic, the lifespan of an infected epithelial cell is shortened to at most 1 day (INFECT LIFESPAN =
24 h) [3].
G. INFECT INIT
This parameter represents the magnitude of the initial dose of influenza A virus delivered to test volunteers in
viral replication experiments. In particular, in our model this is the fraction of epithelial cells initially set in the
infected state. This parameter’s value is not bounded physiologically, rather it is an arbitrary initial condition. In
studies of the influenza A virus reported in [3], the typical initial concentration of aerosol-delivered virions is about
108 virions/mL. Since the average concentration of epithelial cells in the area typically affected by influenza varies
from 109 cells/mL to 1010 cells/mL, and a single epithelial cell can absorb from 1 to 10 influenza virions, then the
typical fraction of cells initially infected is computed to be
INFECT INIT =
108 virions/mL
(109 ∼ 1010) cells/mL× (1 ∼ 10) virions/cell
= 0.001 ∼ 0.1.
We have chosen a default value of 0.01 — the logarithmic middle of the range. Figure 7 presents the effect on
the model’s dynamics of varying INFECT INIT over this range. One sees that the evolution and the outcome of the
infection is dependent upon the initial infective dose received. This reflects the competitive nature of the disease and
immune system interaction: if one starts with too large a numerical advantage over the other, the latter is bound to
loose.
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FIG. 8: The effect of varying INFECT RATE on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using INFECT RATE values of 1, 2, and 4 infected neighbour(s) · h−1 respectively. The central graph is the same as
Figure 1. These show that the simulation is sensitive to the parameter INFECT RATE.
H. INFECT RATE
The growth rate of the infection in our model is determined by the parameter INFECT RATE, which is defined as the
number of its neighbours that an infectious cell will infect per hour. This parameter was not found in the literature as
it does not correspond directly to the true biological process of infection. In fact, 6 h after a cell has been infected by
the influenza A virus, it begins to release influenza A virions (virus particles) into its surrounding and it is those virions
that move on to infect neighbouring cells. In our model, we have decided not to consider virions at all and instead have
modelled the infection process by the direct infection of neighbouring cells by infectious cells. This is computationally
simpler and more efficient. Throughout influenza A literature, however, the infection growth is described in terms
of the viral titer over the course of the infection rather then as a growth rate. This makes it difficult to establish
the parameter INFECT RATE from experimental data. We have chosen to make it a free parameter and found that we
obtained the best results by setting it to 2.0 h−1, which means that an infectious cell will, on average, infect 2 of its 8
nearest neighbours per hour. One expects that a smaller value of this parameter will yield a less pronounced infection
while larger values will increase the amplitude of the infection and potentially result in the death of the host. This
is illustrated in Figure 8 where we have explored the effect of using a value 1/2× (1 infected neighbour · h−1) and a
value 2× (4 infected neighbours · h−1) the default.
I. BASE IMM CELL
The viral infection model only concerns itself with immune cells that have a role to play in the viral infection, i.e.
those immune cells with a receptor capable of recognizing an epitope of the viral strain present in the simulation.
There must always remain a minimum density of cells capable of recognizing and responding to a new outbreak,
and this density is set by the parameter BASE IMM CELL. The value for BASE IMM CELL was calculated based on the
following information. It has been determined [23] that intraepithelial lymphocytes have a frequency of about 15 per
100 epithelial cells. Further, the probability that an immune cell chosen at random will recognize an epitope chosen
at random is typically 10−5 [17]. Finally, taking into account memory and cross-reactivity phenomena in the case of
influenza A in adults, it is suggested in [3] that the fraction of B or T cells capable of responding to a viral infection
with influenza A be increased by 100-fold. Thus, BASE IMM CELL is calculated to be (15/100)×10−5×100 = 1.5×10−4
virgin immune cells per epithelial cell.
J. RECRUITMENT
When a mature immune cell encounters an infected epithelial cell presenting a viral peptide, the mature immune
cell will “recruit” a number of new mature immune cells. The number of newly created mature immune cells is set
through the parameter RECRUITMENT. This parameter is one of the two free parameters of the model, and it has no
direct biological basis because the immune cells in our model are generic. This parameter represents the efficiency
with which the immune system responds to the viral infection. We explored a range of values for RECRUITMENT, and
found that a value of 0.25, i.e. a 25% chance of recruiting a mature immune cell upon each successful recognition,
gives satisfying results.
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FIG. 9: The effect of varying RECRUITMENT on the viral infection’s dynamics. From left to right, the graphs show the behaviour
obtained using RECRUITMENT values of 0.05, 0.25, and 1.25 respectively. The central graph is the same as Figure 1. These show
that the simulation is sensitive to the parameter RECRUITMENT.
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FIG. 10: The effect of varying RECRUIT DELAY on the viral infection’s dynamics. From left to right, the graphs show the
behaviour obtained using RECRUIT DELAY values of 2 h, 7 h, and 12 h respectively. The central graph is the same as Figure 1.
These show that the simulation is not sensitive to the parameter RECRUIT DELAY.
The typical immune cell division time is about 12 h ∼ 24 h [3], which corresponds to a recruitment ranging from 0.08
to 0.16 immune cells per hour. Considering that an immune cell encounters 6 epithelial cells per hour (FLOW RATE = 6
time steps per hour) and that on average about 15% of those cells are infected, then our model’s effective recruitment
rate is about 0.25× 6× 0.15 = 0.23 immune cells per hour, which is higher than the biological range described above.
However, that recruitment range is based soly on the cellular divisions of activated B and T cells and does not take
into consideration the high production of antibodies by plasma B cells which contributes to reducing the infection,
a factor that can account for the higher recruitment rate value required by our model. Simulation runs using a
RECRUITMENT value of 0.05 and 1.25 are presented in Figure 9. One can see that the parameter RECRUITMENT has an
important effect on the development and the outcome of the infection: too small a value makes the infection fatal,
while larger values decrease the amplitude and duration of the infection. It is thus a key parameter and much effort
should be invested in finding a way to draw a parallel between it and true biological parameters.
K. RECRUIT DELAY
Once a “recruitment call” has been made, immune cells are not added immediately to the simulation lattice. The
delay between the call and the actual addition of immune cells corresponds roughly to the typical transfer time of
cytotoxic T lymphocytes from their main area of production — lung associated lymphoid tissue (LALT) compartment
— to the affected area — the mucous compartment — which, in [3], is said to take from 2 h to 12 h. We chose to use
the mid-range value of 7 h RECRUIT DELAY’s default value. Figure 10 shows the effect of varying RECRUIT DELAY over
the biologically acceptable range. It is clear that changes to the value of this parameter have little influence on the
dynamics of the model over the uncertainty range.
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VI. CONCLUSION
Here, we have introduced a CA model for an uncomplicated viral infection. We have shown that once parameterized
for the particular case of influenza A, our CA model — which is described by 7 state variables and 12 parameters —
is sophisticated enough to reproduce the basic dynamical features of the infection. One expects a 12 parameter model
to be able to match 7 dynamical features, however all but 5 parameters of this model are sufficiently-well bound by
physiological data that they cannot be used to tune its behaviour. Remarkably, our 7 variable and 12 parameter
model’s agreement with the experimental dynamical characteristics compares well to that of the 13 variable and 60
parameter model presented in [3]. To the authors’ knowledge, the CA model presented here along with the ODE
model presented in [3] are the only two existing immunological models for influenza A viral infections. This is
quite surprising considering its significance to human health worldwide, particularly its high potential for causing
devastating epidemics [25].
The results obtained with the model described herein have surpassed our expectations. We had hoped to develop
a model that would be good enough to be used as a test bench to investigate various theoretical aspects of viral
infections, and we have obtained an influenza A model that behaves impressively well when compared against available
experimental data. We believe that by adding additional details to the model such as specific immune cell types, our
CA model could be a very promising model of influenza A.
A wide range of behaviours were observed as the model’s parameters were varied over their biologically allowed
range. It would be valuable to test whether these predicted behaviours can actually be observed in vivo, since if they
are not seen then that would falsify the model.
In future work, we will make use of the CA model introduced here to investigate various theoretical aspects of
viral infections, for example the extent to which such things as spatial inhomogeneities and age classes can affect the
evolution and outcome of a viral infection. It will be interesting to compare this CA model against the recent work in
[5] which makes use of a stochastic stage-structured model, an alternative to both differential equations and cellular
automata.
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